Covered recipient · General Payments record
JOHN FOX
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,073.53
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.19 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $146.80 | 17 |
| Merck Sharp & Dohme Corporation | $52.93 | 3 |
| GENZYME CORPORATION | $39.74 | 2 |
| Acerta Pharma LLC | $39.06 | 2 |
| PFIZER INC. | $25.49 | 1 |
| ITI, Inc. | $17.13 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.35 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746917 | CMS |
| ABBVIE INC. | $8.34 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746919 | CMS |
| ABBVIE INC. | $6.01 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746921 | CMS |
| ABBVIE INC. | $2.10 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746923 | CMS |
| ABBVIE INC. | $2.29 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746925 | CMS |
| ABBVIE INC. | $7.37 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746927 | CMS |
| ABBVIE INC. | $15.99 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746929 | CMS |
| ABBVIE INC. | $8.12 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746931 | CMS |
| ABBVIE INC. | $6.68 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746933 | CMS |
| ABBVIE INC. | $16.42 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746935 | CMS |
| ABBVIE INC. | $14.47 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746937 | CMS |
| ABBVIE INC. | $8.51 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746939 | CMS |
| ABBVIE INC. | $9.95 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746941 | CMS |
| ABBVIE INC. | $6.00 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746943 | CMS |
| ABBVIE INC. | $9.97 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746945 | CMS |
| ABBVIE INC. | $4.39 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746947 | CMS |
| ABBVIE INC. | $3.84 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103746949 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.31 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104252567 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.75 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105566706 | CMS |
| GENZYME CORPORATION | $18.99 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139655529 | CMS |
| GENZYME CORPORATION | $20.75 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139655575 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.13 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143226171 | CMS |
| Merck Sharp & Dohme LLC | $17.22 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141886851 | CMS |
| Merck Sharp & Dohme LLC | $17.23 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141754560 | CMS |
| Merck Sharp & Dohme LLC | $18.48 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141754558 | CMS |
| PFIZER INC. | $25.49 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130926343 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.04 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137549984 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.